Declining sales of blockbuster drug drag Teva revenue lower By: MarketWatch May 02, 2019 at 14:28 PM EDT Declining sales of blockbuster drug Copaxone dragged down first-quarter revenue at Teva Pharmaceuticals Industries Ltd. Read More >> Related Stocks: HEALTHCARE S&P Pharmaceuticals SPDR Teva Pharmaceutical Industries ADR